- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, March 8, 2024
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Articles published by Medriva and BioSpace referenced a study published in the February 2024 issue of The American Journal of Managed Care® (AJMC®). The study, “Unintended Consequences of the Inflation Reduction Act: Clinical Development Toward Subsequent Indications,” examined the clinical development landscape and potential impacts of the Inflation Reduction Act (IRA) of 2022 on high-spend Medicare Part D small molecule drugs, finding that longer development timelines and decreased investments in additional indications could reduce incentives for postapproval research.
An article from Myasthenia Gravis News referenced an article published on AJMC.com, the website of AJMC. The article, “Not So Rare: 300 Million People Worldwide Affected by Rare Diseases,” summarized a study that estimated that approximately 4% of the total world population is affected by a rare disease.
Articles from Medpage Today and Drug Topics® referenced an article published by AJMC’s sister site, The Center for Biosimilars®. The article, “FDA Approves First Denosumab Biosimilars,” reported on the FDA approvals for Sandoz’ Wyost and Jubbonti (both denosumab-bddz) to treat osteoporosis and prevent skeletal-related events associated with bone metastases from solid tumors. The biosimilars are the first approved products to reference originator denosumab (Prolia/Xgeva).
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More
No Major Shifts in OBGYN Practice Locations Found Post Dobbs Decision
April 21st 2025Despite widespread concern following the Dobbs v Jackson Women’s Health Organization decision, researchers found no significant changes nationwide in obstetrician and gynecologist (OBGYN) practice locations.
Read More
